Exploring September 2026's Undervalued Small Caps With Insider Buying

The United States market has experienced a 13% drop in the last week, although it remains up by 13% over the past year, with earnings expected to grow annually by 18%. In this fluctuating environment, identifying small-cap stocks that are perceived as undervalued and have insider buying can offer unique opportunities for investors seeking potential growth.

Top 10 Undervalued Small Caps With Insider Buying In The United States

Name	PE	PS	Discount to Fair Value	Value Rating
Regional Management	6.0x	0.4x	38.43%	★★★★★☆
Financial Institutions	9.6x	3.2x	23.81%	★★★★★☆
Cardinal Infrastructure Group	NA	0.9x	42.12%	★★★★★☆
Surgery Partners	NA	0.6x	23.22%	★★★★★☆
Enovis	NA	0.5x	44.74%	★★★★★☆
Bank of the James Financial Group	10.8x	2.4x	27.40%	★★★★☆☆
Union Bankshares	9.4x	2.0x	46.85%	★★★★☆☆
Shore Bancshares	11.5x	3.3x	37.50%	★★★★☆☆
German American Bancorp	13.1x	4.9x	28.02%	★★★☆☆☆
Orion Group Holdings	93.8x	0.4x	49.37%	★★★☆☆☆

Click here to see the full list of 65 stocks from our Undervalued US Small Caps With Insider Buying screener.

Underneath we present a selection of stocks filtered out by our screen.

Commercial Bancgroup (CBK)

Simply Wall St Value Rating: ★★★★☆☆

Overview: Commercial Bancgroup operates in the banking sector, focusing on providing a range of financial services with a market capitalization of $1.35 billion.

Operations: Commercial Bancgroup's revenue primarily comes from its banking segment, with recent figures showing $92.55 million. The company has consistently achieved a gross profit margin of 100% over the past nine periods. Operating expenses have been significant, with general and administrative expenses being the largest component, reaching $35.27 million in recent quarters. Net income margins have varied slightly, peaking at 42.53%.

PE: 11.1x

Commercial Bancgroup, a smaller financial entity in the U.S., has shown promising growth with net interest income rising to US$21.52 million in Q2 2026 from US$20.06 million a year earlier. Net income also increased to US$10.22 million from US$8.9 million over the same period, indicating potential undervaluation in its current market stance. Insider confidence is evident as they purchased shares recently, suggesting belief in future prospects bolstered by forecasted earnings growth of 6.83% annually.

• Get an in-depth perspective on Commercial Bancgroup's performance by reading our valuation report here.

• Review our historical performance report to gain insights into Commercial Bancgroup's's past performance.

First Financial (THFF)

Simply Wall St Value Rating: ★★★★★☆

Overview: First Financial is a financial services company primarily engaged in banking operations, with a market capitalization of $0.52 billion.

Operations: First Financial's primary revenue stream is from its banking operations, which generated $268.17 million in the most recent period. The company consistently achieved a gross profit margin of 100%, indicating all revenue translates directly into gross profit. Operating expenses are significant, with general and administrative expenses being a major component, reaching $114.35 million recently. The net income margin has shown variability over time, with the latest figure at 31.61%.

PE: 10.5x

First Financial, a smaller U.S. company, shows potential for investors seeking value. Recent earnings reveal net income of US$22.74 million for Q2 2026, up from US$18.59 million the previous year, indicating solid financial health. Insider confidence is evident with executives purchasing shares in early 2026, signaling belief in its growth prospects. Leadership changes are underway as Paul Nungester prepares to take over key roles by January 2027, bringing extensive experience that could steer future growth effectively.

• Click here and access our complete valuation analysis report to understand the dynamics of First Financial.

• Gain insights into First Financial's historical performance by reviewing our past performance report.

Chiron Real Estate (XRN)

Simply Wall St Value Rating: ★★★☆☆☆

Overview: Chiron Real Estate focuses on investing in medical properties and has a market capitalization of $2.75 billion.

Operations: Chiron Real Estate generates revenue primarily from investing in medical properties, with a recent gross profit margin of 100%. The company has experienced fluctuations in net income, with the most recent quarter showing a net income margin of 32.03%, reflecting significant non-operating income.

PE: 9.5x

Chiron Real Estate, a smaller player in the U.S. market, has shown remarkable financial improvement with net income rising to US$66.27 million in Q2 2026 from US$0.655 million a year prior. Despite this surge, earnings are expected to decline significantly over the next three years. The company recently declared dividends on both common and preferred stocks for upcoming months, signaling confidence in its cash flow stability. However, insider confidence remains unclear due to no recent insider buying activity reported during this period.

• Take a closer look at Chiron Real Estate's potential here in our valuation report.

• Assess Chiron Real Estate's past performance with our detailed historical performance reports.

Next Steps

• Navigate through the entire inventory of 65 Undervalued US Small Caps With Insider Buying here.
• Are any of these part of your asset mix? Tap into the analytical power of Simply Wall St's portfolio to get a 360-degree view on how they're shaping up.
• Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.

Want To Explore Some Alternatives?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com